These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30614342)

  • 1. Effects of the combination of metformin and exercise on glycated hemoglobin, functional capacity, lipid profile, quality of life, and body weight.
    Eltonsy S; Dufour Doiron M; Simard P; Jose C; Sénéchal M; Bouchard DR; LeBlanc R; Bélanger M
    J Int Med Res; 2019 Mar; 47(3):1131-1145. PubMed ID: 30614342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of metformin in type 1 diabetes mellitus.
    Beysel S; Unsal IO; Kizilgul M; Caliskan M; Ucan B; Cakal E
    BMC Endocr Disord; 2018 Jan; 18(1):1. PubMed ID: 29338714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic Efficacy and Metabolic Consequences of an Empagliflozin Add-on versus Conventional Dose-Increasing Strategy in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea.
    Shin Y; Moon JH; Chin HJ; Ferrannini E; Lim S
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):329-338. PubMed ID: 32615717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metformin combined with lifestyle modification versus lifestyle modification alone on proinflammatory-oxidative status in drug-naïve pre-diabetic and diabetic patients: A randomized controlled study.
    Bulatova N; Kasabri V; Qotineh A; Al-Athami T; Yousef AM; AbuRuz S; Momani M; Zayed A
    Diabetes Metab Syndr; 2018 May; 12(3):257-267. PubMed ID: 29221717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin as a potential protective therapy against tuberculosis in patients with diabetes mellitus: A retrospective cohort study in a single teaching hospital.
    Fu CP; Lee CL; Li YH; Lin SY
    J Diabetes Investig; 2021 Sep; 12(9):1603-1609. PubMed ID: 33550691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
    Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naïve patients with type 2 diabetes: initial triple study.
    Lim S; Ku EJ; Lee SY; Lee JH; Lee JE; Kim KM; Davies MJ
    BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment.
    Tao T; Wu P; Wang Y; Liu W
    BMC Endocr Disord; 2018 Feb; 18(1):14. PubMed ID: 29482528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Roberts VL; Stewart J; Issa M; Lake B; Melis R
    Clin Ther; 2005 Oct; 27(10):1535-47. PubMed ID: 16330290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Exercise with or Without Metformin on Glucose Profiles in Type 2 Diabetes: A Pilot Study.
    Myette-Côté É; Terada T; Boulé NG
    Can J Diabetes; 2016 Apr; 40(2):173-7. PubMed ID: 26711719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of vitamin C and/or E supplementations on type 2 diabetic adult males under metformin treatment: A single-blinded randomized controlled clinical trial.
    El-Aal AA; El-Ghffar EAA; Ghali AA; Zughbur MR; Sirdah MM
    Diabetes Metab Syndr; 2018 Jul; 12(4):483-489. PubMed ID: 29571976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of self-monitoring of blood glucose in relation to weight loss and A1C during intensive multidisciplinary weight management in patients with type 2 diabetes and obesity.
    Tomah S; Mahmoud N; Mottalib A; Pober DM; Tasabehji MW; Ashrafzadeh S; Hamdy O
    BMJ Open Diabetes Res Care; 2019; 7(1):e000659. PubMed ID: 31413841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical decisions. Management of type 2 diabetes--polling results.
    Schulte JM; Rothaus CS; Adler JN
    N Engl J Med; 2014 Jan; 370(1):e2. PubMed ID: 24382086
    [No Abstract]   [Full Text] [Related]  

  • 14. Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study.
    Adeshara KA; Bangar NS; Doshi PR; Diwan A; Tupe RS
    Diabetes Metab Syndr; 2020; 14(5):1449-1458. PubMed ID: 32769032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus.
    Meneghini LF; Traylor L; Schwartz SL
    Endocr Pract; 2010; 16(4):588-99. PubMed ID: 20350924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction between metformin and physical activity on postprandial glucose and glucose kinetics: a randomised, clinical trial.
    Pilmark NS; Lyngbæk M; Oberholzer L; Elkjær I; Petersen-Bønding C; Kofoed K; Siebenmann C; Kellenberger K; van Hall G; Abildgaard J; Ellingsgaard H; Lauridsen C; Ried-Larsen M; Pedersen BK; Hansen KB; Karstoft K
    Diabetologia; 2021 Feb; 64(2):397-409. PubMed ID: 32979074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hyperglycemia in minority children with type 2 diabetes mellitus.
    Castells S
    J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():531-40. PubMed ID: 12017228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of vildagliptin as add-on to metformin monotherapy among uncontrolled type 2 diabetes mellitus patients in a real-world setting.
    Melzer Cohen C; Davis C; Shalev V; Chodick G
    J Diabetes; 2018 Jan; 10(1):68-72. PubMed ID: 28418203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent subadditivity of the efficacy of initial combination treatments for type 2 diabetes is largely explained by the impact of baseline HbA1c on efficacy.
    Polidori D; Capuano G; Qiu R
    Diabetes Obes Metab; 2016 Apr; 18(4):348-54. PubMed ID: 26661906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes.
    Hällsten K; Virtanen KA; Lönnqvist F; Sipilä H; Oksanen A; Viljanen T; Rönnemaa T; Viikari J; Knuuti J; Nuutila P
    Diabetes; 2002 Dec; 51(12):3479-85. PubMed ID: 12453903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.